Stock Comparison
ABT vs PHG
Abbott Laboratories and Koninklijke Philips NV ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$26.55B
P/E (TTM)
35.7
20.6
Forward P/E
20.0
14.8
Price/Sales
4.1
1.5
Price/Book
3.7
2.0
EV/EBITDA
18.6
9.6
Dividend Yield
1.66%
3.70%
Profitability
Net Margin
13.91%
6.31%
Operating Margin
18.17%
9.74%
Return on Equity
10.60%
10.20%
Return on Assets
5.33%
4.07%
Growth (YoY)
Revenue Growth
13.00%
0.50%
Earnings Growth
-47.50%
61.40%
Price & Risk
Beta
0.6
0.9
52-Week High
$134.48
$31.66
52-Week Low
$82.56
$24.61
Analyst Target
$118.42
$32.21
Compare ABT and PHG your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.